Empathy and (Self-)Compassion in Parkinson's Disease Patients and Caregivers
ConditionParkinson Disease(PD)
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age50-80
SponsorAlain Kaelin
About this trial
The goal of this clinical trial is to improve quality of life in Parkinson's Disease (PD) patients by increasing their empathy and their (self-)compassion. The main question it aims to answer is:
Does the level of quality of life in PD patients and caregivers improve after empathy/(self-)compassion training?
Participants will be delivered a 6-week empathy and compassion training (mindfulness, writing and poetry exercises addressing the cognitive, emotional, motivational and behavioural components of (self-)compassion) and will also be asked to answer questionnaires before and after the training
Eligibility criteria
Qualifiers
Diagnosis of PD
Hoehn and Yahr scale, stage ≤ 3
Mini Mental State Examination with a score ≥ 26
Able to give informed consent as documented by signature
Disqualifiers
Any medical condition that is not PD, such as drug induced parkinsonism
Major depression, dysthymia, or according to DSM-V
Other neurological or psychiatric diseases
Neuropsychological scores compatible with the diagnosis of early dementia
Trial design
Treatments tested in this trial
- empathy and compassion training
Treatment groups
30 Participants
are divided into 1 treatment groupSponsors and collaborators
Alain Kaelin
Lead sponsor
Ente Ospedaliero Cantonale, Bellinzona
Sponsor institution
CTU-EOC Clinical Trial Unit Ente Ospedaliero Cantonale
Collaborator
Source ClinicalTrials.gov